- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Portopulmonary Hypertension in Hong Kong
Total 158 results
-
Bristol-Myers SquibbSanofiCompletedHypertensionUnited States, Belgium, Canada, Germany, Russian Federation, France, Israel, Netherlands
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States
-
GlaxoSmithKlineCompletedHypertensionUnited States
-
Forest LaboratoriesCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States, Canada, Czech Republic, Denmark, Estonia, Finland, France, Germany, Lebanon, Netherlands, Norway, Sweden
-
Boehringer IngelheimCompletedHypertension | Diabetes Mellitus, Type 2Taiwan, Korea, Republic of, United States, New Zealand, Australia, Argentina, Canada, Mexico
-
AstraZenecaRecruitingChronic Kidney Disease and HypertensionSpain, United States, Argentina, Denmark, Italy, Sweden, United Kingdom, Belgium, France, Turkey, China, Germany, Saudi Arabia, Thailand, Vietnam, Australia, Serbia, Brazil, Canada, Japan, Malaysia, Philippines, Poland, Taiwan, Greece, Is... and more
-
KBP BiosciencesActive, not recruitingChronic Kidney DiseasesChina, Spain, Australia, Hungary, Malaysia, United States, Germany, Bulgaria, Serbia, Hong Kong, Georgia, Bosnia and Herzegovina, Croatia, Czechia, South Africa, Canada, Israel, Korea, Republic of, Latvia, Lithuania, Poland, Taiwan